Abstract
Genetic Engineering & Biotechnology NewsVol. 31, No. 19 Wall Street BiobeatVolatility Rattles Biotechnology SectorUncertainty Will Continue Until Policy Makers Find Path to Sustainabile Global Economic StabilityEugene RozelmanEugene RozelmanEugene Rozelman (E-mail Address: erozelman@canaccordgenuity.com) is a principal in the life sciences investment banking sector at Canaccord Genuity (CGI).CGI has received compensation from Raptor Pharmaceutical and Optimer Pharmaceuticals for investment banking activity in the past 12 months. For regulatory disclosures visit www.canaccordgenuity.com/EN/about/Pages/Disclosures.aspx.Search for more papers by this authorPublished Online:22 Oct 2011https://doi.org/10.1089/gen.31.19.06AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 31Issue 19Nov 2011 Information© 2011 by GEN PublishingTo cite this article:Eugene Rozelman.Volatility Rattles Biotechnology Sector.Genetic Engineering & Biotechnology News.Nov 2011.17-17.http://doi.org/10.1089/gen.31.19.06Published in Volume: 31 Issue 19: October 22, 2011PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
